SMI
11.934,17
PKT
+152,43
PKT
+1,29
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.01.18 | Roche overweight | JP Morgan Chase & Co. | |
11.01.18 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
11.01.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
11.01.18 | Nestlé Neutral | UBS AG | |
10.01.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
10.01.18 | Nestlé overweight | JP Morgan Chase & Co. | |
10.01.18 | Givaudan overweight | JP Morgan Chase & Co. | |
10.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
10.01.18 | UBS Hold | Société Générale Group S.A. (SG) | |
10.01.18 | Holcim Hold | Deutsche Bank AG | |
10.01.18 | UBS Hold | Société Générale Group S.A. (SG) | |
09.01.18 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
09.01.18 | ABB (Asea Brown Boveri) Neutral | Merrill Lynch & Co., Inc. | |
08.01.18 | Holcim Outperform | Bernstein Research | |
08.01.18 | Givaudan Underperform | Bernstein Research | |
08.01.18 | Roche Neutral | UBS AG | |
08.01.18 | Givaudan Underperform | Bernstein Research | |
05.01.18 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
05.01.18 | Swiss Re buy | Deutsche Bank AG | |
05.01.18 | Zurich Insurance Hold | Kepler Cheuvreux | |
05.01.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
05.01.18 | UBS Sector Perform | RBC Capital Markets | |
05.01.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
05.01.18 | Swiss Re Sell | UBS AG | |
05.01.18 | Roche buy | Jefferies & Company Inc. | |
04.01.18 | UBS buy | UBS AG | |
04.01.18 | Swiss Re buy | Deutsche Bank AG | |
04.01.18 | Zurich Insurance Hold | Deutsche Bank AG | |
03.01.18 | Givaudan overweight | JP Morgan Chase & Co. | |
03.01.18 | Nestlé overweight | JP Morgan Chase & Co. | |
03.01.18 | Zurich Insurance Hold | Jefferies & Company Inc. | |
03.01.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
29.12.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
29.12.17 | Roche overweight | JP Morgan Chase & Co. | |
29.12.17 | Novartis Neutral | JP Morgan Chase & Co. | |
27.12.17 | Novartis Halten | Norddeutsche Landesbank (Nord/LB) | |
27.12.17 | Roche kaufen | Norddeutsche Landesbank (Nord/LB) | |
21.12.17 | Roche overweight | Barclays Capital | |
20.12.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
18.12.17 | UBS Sector Perform | RBC Capital Markets |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.